Senior Scientist

QP Group; Dallas (TX); On-site; USD 120,000 - 170,000; Full time

Job summary

QP Group is seeking a Senior Scientist in Texas to lead analytical development for neonatal progenitor cell therapy projects. The role focuses on characterizing cell products and processes, partnering with CDMOs and collaborators to ensure robust analytics and scalable transfer into manufacturing.

The successful candidate will design, develop, and qualify assays (Flow Cytometry, ELISA, qPCR), interpret data, and document experiments with clear protocols and reports.

Qualifications

• PhD or Master’s in cell biology, immunology, biochemistry, or bioengineering.
• 5+ years in analytical development for cell therapy or gene therapy products.
• Experience with Flow Cytometry assays and their development to qualification.
• Strong experimental design and result interpretation.
• Ability to document outcomes in protocols and reports.
• Strong written and verbal communication skills.
• Ability to work independently and in a small-company environment.

Responsibilities

• Development and optimization of analytical methods and potency assays for characterization of cell therapy products (Flow Cytometry, ELISA, qPCR).
• Collaboration with CDMOs and CTLs to facilitate Tech Transfer of analytical methods.
• Support additional projects and business needs as assigned.
• Execution of analytical testing for in-process samples, cell banks and cell products.

Skills

Flow Cytometry

ELISA

qPCR

Experimental design

Data interpretation

Documentation (protocols/reports)

CDMOs collaboration

Education

PhD or Master’s in cell biology, immunology, biochemistry, or bioengineering

Job description

*** Senior Scientist Opportunity - Texas ***

QP Group is currently partnered with a clinical-stage, Series A-backed biotech developing a neonatal progenitor cell therapy for rare cardiomyopathies, with its lead programme advancing towards pivotal trials in a neuromuscular disease-related heart condition. a Scientist/Senior Scientist to support the Analytical Development within the CMC Group. This role will be responsible for characterization of cell products and processes and will work closely with the Process Development team and external partners such as CDMOs and collaborators.

Responsibilities:

• Development and optimization of analytical methods and potency assays for the characterization of cell therapy products, including those based on Flow Cytometry, ELISA, and qPCR
• Collaboration with CDMOs and CTLs to facilitate Tech Transfer of analytical methods
• Support additional projects and business needs as assigned
• Execution of analytical testing for in-process samples, cell banks and cell products

Experience Required:

• PhD or Master's degree in cell biology, immunology, biochemistry, or bioengineering
• 5+ years of experience in analytical development, analytical/product characterization for cell therapy or gene therapy drug products
• Experience with Flow Cytometry assays and their development to qualification
• Strong background in experimental design and result interpretation
• Ability to optimize and performance-evaluate characterization methods to ensure they are scientifically sound and fit for purpose, documenting outcomes in protocols and reports
• Strong written and verbal communication skills
• Ability to work independently, manage priorities, and collaborate effectively in a small-company environment